James Jones - Net Worth and Insider Trading

James Jones Net Worth

The estimated net worth of James Jones is at least $45,066 dollars as of 2024-11-12. James Jones is the Director of Cumberland Pharmaceuticals Inc and owns about 37,871 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $45,066. Details can be seen in James Jones's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Jones has not made any transactions after 2024-10-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Jones

To

James Jones Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Jones owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of James Jones’s form 4 insider trades.

Insider Ownership Summary of James Jones

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2024-10-31 director

James Jones Latest Holdings Summary

James Jones currently owns a total of 1 stock. James Jones owns 37,871 shares of Cumberland Pharmaceuticals Inc (CPIX) as of October 31, 2024, with a value of $45,066.

Latest Holdings of James Jones

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2024-10-31 37,871 1.19 45,066

Holding Weightings of James Jones


James Jones Form 4 Trading Tracker

According to the SEC Form 4 filings, James Jones has made a total of 15 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 15 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 1,426 shares on October 31, 2024, which cost James Jones around $1,825.

Insider Trading History of James Jones

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Jones Trading Performance

GuruFocus tracks the stock performance after each of James Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Jones is 3.08%. GuruFocus also compares James Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Jones within 3 months outperforms 8 times out of 15 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Jones's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Jones

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 15 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.95 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.49 LIMIT LIMIT LIMIT LIMIT LIMIT

James Jones Ownership Network

Ownership Network List of James Jones

No Data

Ownership Network Relation of James Jones

Insider Network Chart

James Jones Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

James Jones is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO A J Kazimi , Vice Pres Sales & Marketing Chris T. Bitterman , and Vice Pres Organizational Dev Todd M. Anthony .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, James Jones made 1 insider transaction in Cumberland Pharmaceuticals Inc (CPIX) with a net purchase of 1,426. Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 7,107 shares made by Kenneth Krogulski , a net purchase of 1,426 shares made by A J Kazimi , and a net purchase of 713 shares made by Caroline Young .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 10,672 shares, with a net purchase of 10,672 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 10,672 shares were bought by its insiders, resulting in a net purchase of 10,672 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

James Jones Mailing Address

Above is the net worth, insider trading, and ownership report for James Jones. You might contact James Jones via mailing address: 2525 West End Ave., Suite 950, Nashville Tn 37203.